PER2 and depressive symptom measurement: Our study demonstrated significant associations between cognitive impairment, sleep quality, marital status fosaprepitant intake, and PER2 polymorphism and depression levels, whereas anxiety levels were significantly associated to cognitive impairment, insomnia severity, fosaprepitant intake, and COMT polymorphism.